PhysIQ Closes $8 Million in Series B Financing | Read the press release here.

Who We Are

The physIQ team has been successfully developing highly innovative solutions for monitoring the health of complex systems for more than a decade.  Our core management team members are pioneers of IoT, with unparalled experience in developing and commercializing transformational machine-learning analytics for time-series sensor data...

Liviu Klein, MD


Dr. Liviu Klein, a cardiologist at the UCSF Heart and Vascular Center, is director of the Mechanical Circulatory Support and Heart Failure Device Program. He specializes in treating patients with heart failure and arrhythmias, including patients before and after heart transplants. He also has expertise in cardiac resynchronization and mechanical therapies such as ventricular assist devices for heart failure. In his research, he studies the epidemiology of heart failure in women, including those at risk for sudden cardiac death. Together with colleagues in the department of Bioengineering and Therapeutic Sciences at UCSF, he is developing new sensor technologies for monitoring and treating patients with heart failure, and for those who use ventricular assist devices.

Klein earned a medical degree at the Carol Davila School of Medicine in Bucharest, Romania, and earned a master's of science in clinical investigation at Northwestern University in Evanston, Ill.. Klein is a member of the American Heart Association, Heart Failure Society of America and International Society for Lung and Heart Transplant. He has published more than 60 peer-reviewed articles and books. At UCSF, he is an assistant professor of clinical medicine.

Contact us and transform the future of real-world patient insight.

At physIQ, we welcome the opportunity to speak with potential customers, partners, or anyone with an interest in learning more about the transformative potential of our technology.

CONTACT US